HHS logo

Harte Hanks (HHS) EBITDA

Annual EBITDA

$13.28 M
-$4.55 M-25.52%

December 31, 2023

Summary

Performance

1-Year Change

-25.52%

3-Year Change

+198.17%

5-Year Change

+197%

15-Year Change

+219.92%

HHS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.26%
HHS annual EBITDA is higher than 36.26% of companies in Industrials sector

High & Low

All-time High

$221.52 M
HHS annual EBITDA is currently -94.00% below its historical high of $221.52 million

3-Year Low

$13.28 M
HHS annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
HHS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 14, 2025
HHS next annual earnings announcement is scheduled for Mar 14, 2025

OtherHHSprofitabilitymetrics:

Annual Revenue

$191.49 M
HHS annual revenue is $191.49 million

Annual Net Income

-$1.57 M
HHS annual net profit is -$1.57 million

Annual EBIT

$9.05 M
HHS annual earnings before interest & taxes is $9.05 million

Annual EPS

-$0.21
HHS annual earnings per share is -$0.21

Quarterly EBITDA

$3.77 M
+$951.00 K+33.70%

September 30, 2024

Summary

Performance

3-Month Change

+33.7%

1-Year Change

+362.94%

3-Year Change

-16.02%

5-Year Change

-16.02%

HHS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.02%
HHS quarterly EBITDA is higher than 31.02% of companies in Industrials sector

High & Low

All-time High

$59.99 M
HHS quarterly EBITDA is currently -93.71% below its historical high of $59.99 million

3-Year Low

-$1.56 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
HHS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
HHS next earnings announcement is scheduled for Mar 14, 2025

OtherHHSprofitabilitymetrics:

Quarterly Revenue

$47.63 M
HHS quarterly revenue is $47.63 million

Quarterly Net Income

$142.00 K
HHS quarterly net profit is $142.00 thousand

Quarterly EBIT

$2.73 M
HHS quarterly earnings before interest & taxes is $2.73 million

Quarterly EPS

$0.02
HHS quarterly earnings per share is $0.02

TTM EBITDA

$12.01 M
-$93.00 K-0.77%

September 30, 2024

Summary

Performance

3-Month Change

-0.77%

1-Year Change

+0.22%

3-Year Change

-50.83%

5-Year Change

-50.83%

HHS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.53%
HHS TTM EBITDA is higher than 30.53% of companies in Industrials sector

High & Low

All-time High

$223.46 M
HHS TTM EBITDA is currently -94.63% below its historical high of $223.46 million

3-Year Low

$7.13 M
HHS TTM EBITDA is currently +68.37% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
HHS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
HHS next earnings announcement is scheduled for Mar 14, 2025

OtherHHSprofitabilitymetrics:

TTM Revenue

$187.60 M
HHS TTM revenue is $187.60 million

TTM Net Income

-$29.84 M
HHS TTM net profit is -$29.84 million

TTM EBIT

$7.71 M
HHS TTM earnings before interest & taxes is $7.71 million

TTM EPS

-$4.11
HHS TTM earnings per share is -$4.11

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$13.28 M
HHS annual EBITDA is $13.28 million

Annual Net Income

-$1.57 M
HHS annual net profit is -$1.57 million

Annual Interest Expense

-
HHS annual interest expense value is unknown

Annual Income Tax

-$349.00 K
HHS annual income tax is -$349.00 thousand

Annual D&A

$4.24 M
HHS annual depreciation & amortization is $4.24 million

HHS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-25.5%+362.9%+0.2%
3 y3 years+198.2%-16.0%-50.8%
5 y5 years+197.0%-16.0%-50.8%

HHS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-32.6%at low-58.3%+342.2%-50.8%+68.4%
5 y5-year-32.6%+198.2%-71.1%+158.8%-50.8%+188.7%
alltimeall time-94.0%+197.0%-93.7%+102.7%-94.6%+115.0%

Harte Hanks EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.77 M(+33.7%)
$12.01 M(-0.8%)
Jun 2024
-
$2.82 M(+246.3%)
$12.10 M(+1.0%)
Mar 2024
-
$815.00 K(-82.3%)
$11.98 M(-9.8%)
Dec 2023
$13.28 M(-25.5%)
$4.59 M(+18.9%)
$13.28 M(+86.3%)
Sep 2023
-
$3.87 M(+43.0%)
$7.13 M(-42.1%)
Jun 2023
-
$2.70 M(+27.6%)
$12.31 M(-20.2%)
Mar 2023
-
$2.12 M(-236.0%)
$15.42 M(-13.3%)
Dec 2022
$17.84 M(-9.6%)
-$1.56 M(-117.2%)
$17.80 M(-19.9%)
Sep 2022
-
$9.05 M(+55.7%)
$22.23 M(+19.6%)
Jun 2022
-
$5.81 M(+29.4%)
$18.59 M(-23.9%)
Mar 2022
-
$4.49 M(+56.3%)
$24.41 M(+23.8%)
Dec 2021
$19.72 M(-245.8%)
$2.88 M(-46.8%)
$19.72 M(+30.3%)
Sep 2021
-
$5.41 M(-53.6%)
$15.13 M(+66.9%)
Jun 2021
-
$11.64 M(-5892.0%)
$9.07 M(-200.9%)
Mar 2021
-
-$201.00 K(-88.3%)
-$8.99 M(-33.6%)
Dec 2020
-$13.53 M(+203.0%)
-$1.72 M(+160.4%)
-$13.53 M(-1192.9%)
Sep 2020
-
-$659.00 K(-89.7%)
$1.24 M(-152.1%)
Jun 2020
-
-$6.41 M(+35.2%)
-$2.38 M(-227.3%)
Mar 2020
-
-$4.74 M(-136.3%)
$1.87 M(-141.8%)
Dec 2019
-$4.47 M(-67.4%)
$13.05 M(-405.5%)
-$4.46 M(-76.8%)
Sep 2019
-
-$4.27 M(+97.0%)
-$19.21 M(-2.2%)
Jun 2019
-
-$2.17 M(-80.4%)
-$19.65 M(-10.2%)
Mar 2019
-
-$11.07 M(+552.2%)
-$21.88 M(+61.2%)
Dec 2018
-$13.69 M(-429.8%)
-$1.70 M(-63.9%)
-$13.58 M(+55.8%)
Sep 2018
-
-$4.71 M(+6.8%)
-$8.71 M(+1635.7%)
Jun 2018
-
-$4.41 M(+59.0%)
-$502.00 K(-110.5%)
Mar 2018
-
-$2.77 M(-187.5%)
$4.78 M(+15.0%)
Dec 2017
$4.15 M(-247.4%)
$3.17 M(-9.6%)
$4.15 M(-48.7%)
Sep 2017
-
$3.51 M(+302.1%)
$8.09 M(+120.9%)
Jun 2017
-
$872.00 K(-125.7%)
$3.66 M(-622.9%)
Mar 2017
-
-$3.39 M(-147.8%)
-$700.00 K(-75.2%)
Dec 2016
-$2.82 M(-111.6%)
$7.10 M(-872.0%)
-$2.82 M(-241.3%)
Sep 2016
-
-$920.00 K(-73.6%)
$1.99 M(-68.9%)
Jun 2016
-
-$3.49 M(-36.7%)
$6.41 M(-60.3%)
Mar 2016
-
-$5.51 M(-146.3%)
$16.13 M(-42.6%)
Dec 2015
$24.36 M(-36.2%)
$11.91 M(+241.0%)
$28.09 M(+64.9%)
Sep 2015
-
$3.49 M(-44.0%)
$17.04 M(-38.6%)
Jun 2015
-
$6.23 M(-3.4%)
$27.76 M(-23.3%)
Mar 2015
-
$6.45 M(+649.4%)
$36.21 M(-5.1%)
Dec 2014
$38.17 M(-37.6%)
$861.00 K(-93.9%)
$38.17 M(-29.0%)
Sep 2014
-
$14.22 M(-3.1%)
$53.75 M(-1.5%)
Jun 2014
-
$14.68 M(+74.4%)
$54.59 M(-2.7%)
Mar 2014
-
$8.42 M(-48.8%)
$56.09 M(-8.3%)
Dec 2013
$61.15 M(-22.2%)
$16.43 M(+9.1%)
$61.15 M(-14.5%)
Sep 2013
-
$15.06 M(-7.0%)
$71.48 M(-4.8%)
Jun 2013
-
$16.19 M(+20.2%)
$75.08 M(-194.8%)
Mar 2013
-
$13.47 M(-49.7%)
-$79.22 M(+6.9%)
Dec 2012
$78.59 M(-10.4%)
$26.76 M(+43.4%)
-$74.14 M(-7.6%)
Sep 2012
-
$18.66 M(-113.5%)
-$80.25 M(+10.7%)
Jun 2012
-
-$138.12 M(-844.4%)
-$72.48 M(-183.2%)
Mar 2012
-
$18.55 M(-10.1%)
$87.14 M(-0.6%)
Dec 2011
$87.70 M(-22.4%)
$20.65 M(-21.9%)
$87.70 M(-10.5%)
Sep 2011
-
$26.43 M(+22.9%)
$97.96 M(-2.6%)
Jun 2011
-
$21.50 M(+12.5%)
$100.57 M(-6.4%)
Mar 2011
-
$19.11 M(-38.2%)
$107.47 M(-4.9%)
Dec 2010
$113.04 M(+2.7%)
$30.91 M(+6.5%)
$113.04 M(+4.4%)
Sep 2010
-
$29.04 M(+2.2%)
$108.31 M(-1.4%)
Jun 2010
-
$28.40 M(+15.0%)
$109.87 M(-2.0%)
Mar 2010
-
$24.69 M(-5.7%)
$112.10 M(+1.8%)
Dec 2009
$110.07 M(-27.7%)
$26.18 M(-14.4%)
$110.07 M(-6.2%)
Sep 2009
-
$30.60 M(-0.1%)
$117.35 M(-7.5%)
Jun 2009
-
$30.64 M(+35.2%)
$126.81 M(-9.4%)
Mar 2009
-
$22.66 M(-32.3%)
$139.94 M(-8.0%)
Dec 2008
$152.15 M
$33.46 M(-16.5%)
$152.15 M(-12.7%)
Sep 2008
-
$40.06 M(-8.5%)
$174.20 M(-4.9%)
DateAnnualQuarterlyTTM
Jun 2008
-
$43.77 M(+25.5%)
$183.27 M(-3.7%)
Mar 2008
-
$34.86 M(-37.2%)
$190.23 M(-5.3%)
Dec 2007
$200.83 M(-8.7%)
$55.52 M(+13.0%)
$200.83 M(-1.9%)
Sep 2007
-
$49.13 M(-3.1%)
$204.78 M(-2.0%)
Jun 2007
-
$50.72 M(+11.6%)
$208.90 M(-4.2%)
Mar 2007
-
$45.47 M(-23.5%)
$218.16 M(-0.9%)
Dec 2006
$220.08 M(-0.6%)
$59.47 M(+11.7%)
$220.08 M(+0.0%)
Sep 2006
-
$53.24 M(-11.3%)
$219.99 M(-1.5%)
Jun 2006
-
$59.99 M(+26.6%)
$223.46 M(+2.0%)
Mar 2006
-
$47.39 M(-20.2%)
$219.12 M(-1.1%)
Dec 2005
$221.52 M(+14.1%)
$59.38 M(+4.7%)
$221.54 M(+2.2%)
Sep 2005
-
$56.70 M(+1.9%)
$216.78 M(+2.9%)
Jun 2005
-
$55.65 M(+11.7%)
$210.63 M(+2.6%)
Mar 2005
-
$49.82 M(-8.8%)
$205.21 M(+5.7%)
Dec 2004
$194.16 M(+9.9%)
$54.61 M(+8.0%)
$194.16 M(+3.1%)
Sep 2004
-
$50.55 M(+0.6%)
$188.31 M(+2.6%)
Jun 2004
-
$50.23 M(+29.5%)
$183.54 M(+2.2%)
Mar 2004
-
$38.77 M(-20.5%)
$179.58 M(+1.7%)
Dec 2003
$176.62 M(-3.5%)
$48.76 M(+6.5%)
$176.62 M(+0.3%)
Sep 2003
-
$45.78 M(-1.1%)
$176.03 M(+0.6%)
Jun 2003
-
$46.27 M(+29.2%)
$174.93 M(-1.1%)
Mar 2003
-
$35.81 M(-25.7%)
$176.91 M(-3.4%)
Dec 2002
$183.12 M(-3.0%)
$48.17 M(+7.8%)
$183.12 M(+0.2%)
Sep 2002
-
$44.68 M(-7.4%)
$182.69 M(-2.0%)
Jun 2002
-
$48.25 M(+14.8%)
$186.41 M(-0.3%)
Mar 2002
-
$42.02 M(-12.0%)
$186.90 M(-1.0%)
Dec 2001
$188.76 M(+3.5%)
$47.74 M(-1.4%)
$188.76 M(-0.4%)
Sep 2001
-
$48.40 M(-0.7%)
$189.46 M(+0.9%)
Jun 2001
-
$48.74 M(+11.1%)
$187.83 M(+1.2%)
Mar 2001
-
$43.87 M(-9.4%)
$185.59 M(+1.8%)
Dec 2000
$182.38 M(+18.9%)
$48.44 M(+3.6%)
$182.38 M(+2.9%)
Sep 2000
-
$46.77 M(+0.6%)
$177.30 M(+4.5%)
Jun 2000
-
$46.50 M(+14.4%)
$169.66 M(+4.8%)
Mar 2000
-
$40.66 M(-6.2%)
$161.95 M(+5.6%)
Dec 1999
$153.45 M(+16.7%)
$43.36 M(+10.8%)
$153.32 M(+4.1%)
Sep 1999
-
$39.13 M(+0.9%)
$147.31 M(+3.8%)
Jun 1999
-
$38.80 M(+21.1%)
$141.87 M(+3.6%)
Mar 1999
-
$32.03 M(-14.2%)
$136.97 M(+4.1%)
Dec 1998
$131.55 M(+31.2%)
$37.35 M(+10.8%)
$131.55 M(+4.6%)
Sep 1998
-
$33.70 M(-0.6%)
$125.80 M(+6.6%)
Jun 1998
-
$33.90 M(+27.4%)
$118.00 M(+8.0%)
Mar 1998
-
$26.60 M(-15.8%)
$109.30 M(+8.9%)
Dec 1997
$100.30 M(+25.2%)
$31.60 M(+22.0%)
$100.40 M(+75.5%)
Sep 1997
-
$25.90 M(+2.8%)
$57.20 M(-19.1%)
Jun 1997
-
$25.20 M(+42.4%)
$70.70 M(+11.3%)
Mar 1997
-
$17.70 M(-252.6%)
$63.50 M(-4.8%)
Dec 1996
$80.10 M(+22.1%)
-$11.60 M(-129.4%)
$66.70 M(-6.3%)
Sep 1996
-
$39.40 M(+118.9%)
$71.20 M(+19.7%)
Jun 1996
-
$18.00 M(-13.9%)
$59.50 M(-12.5%)
Mar 1996
-
$20.90 M(-394.4%)
$68.00 M(+2.3%)
Dec 1995
$65.60 M(-27.3%)
-$7.10 M(-125.6%)
$66.50 M(-40.3%)
Sep 1995
-
$27.70 M(+4.5%)
$111.40 M(+7.7%)
Jun 1995
-
$26.50 M(+36.6%)
$103.40 M(+3.1%)
Mar 1995
-
$19.40 M(-48.7%)
$100.30 M(+5.7%)
Dec 1994
$90.20 M(+401.1%)
$37.80 M(+91.9%)
$94.90 M(+18.5%)
Sep 1994
-
$19.70 M(-15.8%)
$80.10 M(+1.4%)
Jun 1994
-
$23.40 M(+67.1%)
$79.00 M(+3.8%)
Mar 1994
-
$14.00 M(-39.1%)
$76.10 M(+3.4%)
Dec 1993
$18.00 M(-74.4%)
$23.00 M(+23.7%)
$73.60 M(+2.5%)
Sep 1993
-
$18.60 M(-9.3%)
$71.80 M(0.0%)
Jun 1993
-
$20.50 M(+78.3%)
$71.80 M(+1.4%)
Mar 1993
-
$11.50 M(-45.8%)
$70.80 M(+0.7%)
Dec 1992
$70.20 M
$21.20 M(+14.0%)
$70.30 M(+43.2%)
Sep 1992
-
$18.60 M(-4.6%)
$49.10 M(+61.0%)
Jun 1992
-
$19.50 M(+77.3%)
$30.50 M(+177.3%)
Mar 1992
-
$11.00 M
$11.00 M

FAQ

  • What is Harte Hanks annual EBITDA?
  • What is the all time high annual EBITDA for Harte Hanks?
  • What is Harte Hanks annual EBITDA year-on-year change?
  • What is Harte Hanks quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Harte Hanks?
  • What is Harte Hanks quarterly EBITDA year-on-year change?
  • What is Harte Hanks TTM EBITDA?
  • What is the all time high TTM EBITDA for Harte Hanks?
  • What is Harte Hanks TTM EBITDA year-on-year change?

What is Harte Hanks annual EBITDA?

The current annual EBITDA of HHS is $13.28 M

What is the all time high annual EBITDA for Harte Hanks?

Harte Hanks all-time high annual EBITDA is $221.52 M

What is Harte Hanks annual EBITDA year-on-year change?

Over the past year, HHS annual EBITDA has changed by -$4.55 M (-25.52%)

What is Harte Hanks quarterly EBITDA?

The current quarterly EBITDA of HHS is $3.77 M

What is the all time high quarterly EBITDA for Harte Hanks?

Harte Hanks all-time high quarterly EBITDA is $59.99 M

What is Harte Hanks quarterly EBITDA year-on-year change?

Over the past year, HHS quarterly EBITDA has changed by +$2.96 M (+362.94%)

What is Harte Hanks TTM EBITDA?

The current TTM EBITDA of HHS is $12.01 M

What is the all time high TTM EBITDA for Harte Hanks?

Harte Hanks all-time high TTM EBITDA is $223.46 M

What is Harte Hanks TTM EBITDA year-on-year change?

Over the past year, HHS TTM EBITDA has changed by +$26.00 K (+0.22%)